A gateway for Ebola/Marburg viruses

Ebola and Marburg viruses (belonging to the family of filoviruses) are two of the most pathogenic viruses in humans, with mortality rates from infection reaching as high as 80%. Effective therapies and vaccines are dependent upon a more complete understanding of the virus life-cycles, including the mechanisms by which these viruses enter and exit the cells they infect. Microdomains sometimes called lipid rafts because of their detergent insoluble and lateral mobility characteristics exist on the outer membranes of cells allowing for the colocalization of molecules necessary for the cells function. Lipid rafts have been implicated in entry, infection and budding of a variety of pathogens including intracellular bacteria and viruses such as HIV.

In the March 4 issue of The Journal of Experimental Medicine, Aman and colleagues from the US Army Medical Research Institute of Infectious Disease, demonstrate that Ebola and Marburg viruses are dependent upon cell membrane lipid rafts for entry into the cell and ultimately for virus assembly and budding, and are thus potential therapeutic targets. They further go on to demonstrate that virus-like particles (VLPs) that do not contain viral genome (and thus are of potential therapeutic utility) can be generated. The authors speculate that these VLPs may have utility as vaccines against these lethal pathogens.


Contact: Lynette Henry
Journal of Experimental Medicine

Page: 1

Related biology news :

1. E-BioSci: Europes gateway to the life sciences
2. Cannabis may help combat cancer-causing herpes viruses
3. Scientists find nanowires capable of detecting individual viruses
4. $7.5 Million grant to Yale researchers for role of viruses in cancer
5. Defensive action by influenza viruses demonstrated by Hebrew university researcher
6. Bright idea could doom cancer and viruses, say Purdue scientists
7. Measuring artificial viruses to improve disease detection
8. Study suggests double punch could more efficiently kill viruses
9. Mite transmits viruses damaging to wheat
10. A new way to kill cancer: SLU research shows viruses can destroy lung, colon tumors
11. Gene with key role in replicating pox viruses also halts inflammation

Post Your Comments:

(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
(Date:6/28/2020)... Fla. (PRWEB) , ... June 25, 2020 , ... In ... focus on innovations in accelerated Point of Care Testing solutions (POCT). Check local listings ... Samples are collected at medical offices and are shipped to labs throughout the country. ...
(Date:6/23/2020)... ... 23, 2020 , ... Rigaku Corporation , a global ... a series of TOPIQ webinars, which will cover the Transferable Aspherical Atom Model ... response to social distancing measures that resulted in postponements and cancelations of global ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... July 17, 2020 , ... ... firm for the life sciences and food industries, is pleased to announce that ... Clinical Research – Business Development. , Charles is an accomplished and results-driven sales ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... Technology (MIT) has expanded the company’s exclusive license to include clinical applications ... point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast ...
(Date:7/10/2020)... , ... July 09, 2020 , ... ... cell therapy, today announced the hiring of Allen R. Nissenson, M.D., F.A.C.P., as ... oversee the clinical development of Sentien’s lead product, SBI-101. Dr. Nissenson serves ...
(Date:7/7/2020)... , ... July 06, 2020 , ... ... Awards. Entries from Roche, Eli Lilly, Bristol-Myers Squibb, the University of Chicago, Massachusetts ... Bio-IT World has hosted an elite awards program, highlighting outstanding examples of how ...
Breaking Biology Technology:
Cached News: